Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Update

Aptevo Therapeutics Inc. (NASDAQ:APVO) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 26,500 shares, an increase of 39.5% from the December 31st total of 19,000 shares. Based on an average daily trading volume, of 265,800 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.8% of the shares of the stock are sold short.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Aptevo Therapeutics in a research note on Monday, December 9th. They issued a “sell” rating on the stock.

Aptevo Therapeutics Trading Down 0.4 %

APVO traded down $0.02 on Friday, reaching $4.44. The company had a trading volume of 8,713 shares, compared to its average volume of 61,881. The business has a 50 day simple moving average of $77.32 and a 200 day simple moving average of $295.41. Aptevo Therapeutics has a 52-week low of $3.65 and a 52-week high of $399.60.

Aptevo Therapeutics Company Profile

Aptevo Therapeutics Inc, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.